Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. PS Ratio 2014–2026
Current and historical P/S ratio for Crescent Biopharma, Inc. (CBIO): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 421.88.
From: 03/31/2014To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Crescent Biopharma, Inc. PS Ratio — FAQ
Crescent Biopharma, Inc. (CBIO) ps ratio over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's ps ratio history?
The chart and table above show Crescent Biopharma, Inc.'s ps ratio by year and by quarter, including the growth rate.